Quarry LP’s Amneal Pharmaceuticals AMRX Stock Holding History

Quarry LP’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,212	Closed	-$12.1K	–	2123
2025 Q3	$12.1K	Buy	+1,212	New	+$10.9K	﹤0.01%	1623

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quarry LP's AMRX Position: Q4 2025 in Review

Quarry LP sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 1,212 shares — an estimated $12.1K sold.

Quarry LP first reported a position in AMRX in Q3 2025 and held it in 1 quarter. The position peaked at $12.1K in Q3 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

Quarry LP reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Quarry LP sold 1,212 Amneal Pharmaceuticals shares in Q4 2025, an estimated $12.1K.
Quarry LP first reported a position in Amneal Pharmaceuticals in Q3 2025 and held it in 1 quarter.
Quarry LP's Amneal Pharmaceuticals position peaked at $12.1K in Q3 2025.
277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.